ES2105984A1 - Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas. - Google Patents

Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.

Info

Publication number
ES2105984A1
ES2105984A1 ES09502370A ES9502370A ES2105984A1 ES 2105984 A1 ES2105984 A1 ES 2105984A1 ES 09502370 A ES09502370 A ES 09502370A ES 9502370 A ES9502370 A ES 9502370A ES 2105984 A1 ES2105984 A1 ES 2105984A1
Authority
ES
Spain
Prior art keywords
gastroenteritis virus
recombinant adenoviruses
vaccines
formulation
transmissible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09502370A
Other languages
English (en)
Other versions
ES2105984B1 (es
Inventor
Duran Juan Plana
Luis Enjuanes
Juan Maria Torres
Carlos Miguel Sanchez
Cristian Smerdou
Carles Sune
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Farma SA
Original Assignee
Cyanamid Iberica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyanamid Iberica SA filed Critical Cyanamid Iberica SA
Priority to ES09502370A priority Critical patent/ES2105984B1/es
Priority to AU71325/96A priority patent/AU7132596A/en
Priority to PCT/ES1996/000185 priority patent/WO1997020036A1/es
Publication of ES2105984A1 publication Critical patent/ES2105984A1/es
Application granted granted Critical
Publication of ES2105984B1 publication Critical patent/ES2105984B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

ADENOVIRUS RECOMBINANTES QUE EXPRESAN ANTIGENOS DEL VIRUS DE LA GASTROENTERITIS PORCIONA TRANSMISIBLE (VGPT) Y SU EMPLEO EN LA FORMULACION DE VACUNAS. LOS ADENOVIRUS RECOMBINANTES CONTIENEN EN SU GENOMA LA SECUENCIA DEL GEN S DEL VIRUS DE LA GASTROENTERITIS PORCINA TRANSMISIBLE (VGPT) O; UNA SECUENCIA DERIVADA DE DICHO GEN QUE CONTIENE, AL MENOS, UNO DE LOS SITIOS ANTIGENICOS DE LA PROTEINA S DEL VGPT. ESTOS ADENOVIRUS RECOMBINANTES PUEDEN UTILIZARSE EN LA FORMULACION DE VACUNAS PARA PROTEGER AL GANADO PORCINO DE LA INFECCION POR VGPT Y CONTRA LA ENFERMEDAD CAUSADA POR DICHO VIRUS. ESTA INVENCION TIENE INTERES EN VETERINARIA.
ES09502370A 1995-11-30 1995-11-30 Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas. Expired - Fee Related ES2105984B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES09502370A ES2105984B1 (es) 1995-11-30 1995-11-30 Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
AU71325/96A AU7132596A (en) 1995-11-30 1996-10-01 Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines
PCT/ES1996/000185 WO1997020036A1 (es) 1995-11-30 1996-10-01 Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formulacion de vacunas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09502370A ES2105984B1 (es) 1995-11-30 1995-11-30 Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.

Publications (2)

Publication Number Publication Date
ES2105984A1 true ES2105984A1 (es) 1997-10-16
ES2105984B1 ES2105984B1 (es) 1998-04-16

Family

ID=8292359

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09502370A Expired - Fee Related ES2105984B1 (es) 1995-11-30 1995-11-30 Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.

Country Status (3)

Country Link
AU (1) AU7132596A (es)
ES (1) ES2105984B1 (es)
WO (1) WO1997020036A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO856097A0 (en) 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
FR2789695B1 (fr) * 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US7569217B2 (en) 2001-09-24 2009-08-04 University Of Saskatchewan Porcine adenovirus E1 and E4 regions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018627A1 (en) * 1990-05-29 1991-12-12 Smithkline Beecham Corporation Swine pneumonia vaccine and method for the preparation thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018627A1 (en) * 1990-05-29 1991-12-12 Smithkline Beecham Corporation Swine pneumonia vaccine and method for the preparation thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CALLEBAUT, P. et al. "Development of a recombinant vector virus for vaccination against viral diarrhoea and respiratory disease in pigs" MEDED. FAC. LANDBOUWWET., UNIV. GENT. 1992. Vol. 57 (4b), pßginas 2077-2084 *
CARLOS M. SANCHEZ et al. "Genetic evolution and tropism of transmissible gastroenteritis coronavirus". VIROLOGY. 1992. Vol. 190, pßginas 92-105 *
CRISTIAN SMERDOU et al. "Induction of an immune response to transmissible gastroenteritis coronavirus using vectors with enteric Tropism" ADV. EXP. MED. BIOL. 1993. Vol. 342 (CORONAVIRUSES), pßginas 455-462 *
LUIS ENJUANES et al. "Antigen selection and presentation to protect against transmissible gastroenteritis coronavirus" VETERINARY MICROBIOLOGY. 1992. Vol. 33, pßginas 249-262 *
SYLVIA HU et al. "Studies of TGEV spike protein Gp 195 expressed in E. Coli and by a TGE-Vaccinia virus recombinant". ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 1985. Vol. 185, pßginas 63-82 *
TORRES, JUAN M. et al. "Induction of Antibodies Protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV Spike protein". VIROLOGY. 10 de noviembre de 1995. Vol. 213, pßginas 503-516 *

Also Published As

Publication number Publication date
AU7132596A (en) 1997-06-19
WO1997020036A1 (es) 1997-06-05
ES2105984B1 (es) 1998-04-16

Similar Documents

Publication Publication Date Title
ATE233101T1 (de) Polynukleotide vakzine gegen den papilloma virus
AR042378A2 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de dicho poxvirus para preparar una vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina
ATE267211T1 (de) Impfstoff gegen hpv
PT1002110E (pt) Respostas imunitarias contra antigenios dos vph suscitadas por composicoes que incorporam um antigenio de vph e uma proteina do stress ou um vector deexpressao com aptidao para a expressao destas proteinas
ATE229978T1 (de) Helicobacter proteine und impstoffe
ATE420190T1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
DK0835133T3 (da) Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf
EP2172551A3 (en) Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
DE3677494D1 (de) Virus-impfstoff.
DK0587780T3 (da) Smitstof, som forårsager Mystery Swine Disease, vaccinepræparater og diagnostiske sæt
BR0111366A (pt) Vacina de poxvìrus recombinante do vìrus da sìndrome respiratória e reprodutiva de porcino (prrsv)
MY150893A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
HU9201746D0 (en) Recombinant avipox virus, the virus infected cell cultivation and the vaccine resulted from it for poultry vaccination
EP1016418A3 (en) Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
HUP9901005A2 (hu) Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B
PT868522E (pt) Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao
ATE319833T1 (de) Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virus
NO964874L (no) Fusjonsglykoprotein fra HCMV og HSV
DE69633919D1 (de) Mehrzweckvakzine gegen umhüllte viren
FR2724385B1 (fr) Vaccin de la peritonite infectieuse feline.
ES2105984B1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
CA2286399A1 (en) Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
DE69428984D1 (de) Stimulierung der immunantwort durch virales protein

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19971016

Kind code of ref document: A1

Effective date: 19971016

FD1A Patent lapsed

Effective date: 20100803